Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 1st July 2016
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Human trial of Hendra vaccine comes to a close
horse
Hendra virus occurs naturally in flying foxes and causes severe disease in horses and humans.
Chief health officer says there were no serious adverse effects
 
A year-long human trial of a Hendra vaccine has come to an end, with no serious adverse effects seen in any of the 40 participants.

Queensland's chief health officer Jeanette Young told AAP that clinical trial results will be released later this year.

The trial involved five groups of eight people, of whom six were administered the monoclonal antibody and two were given a placebo.

Hendra virus occurs naturally in flying foxes and causes severe disease in horses and humans. The route of transmission to horses is thought to be food that has been contaminated with the urine, faeces or foetal fluids of infected bats. Humans become infected through close contact with affected horses.

The virus was first identified in the Brisbane suburb of Hendra in Australia in 1994. According to the Australian Veterinary Association, the last outbreak was reported in September 2015.

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.